Investigating the Interaction Between a Polyphenol-Rich Mediterranean Diet and Genetic Variants on Advanced Glycation End-Product (AGE) Level

Main Article Content

Iqra Walayat
Shaikh Khalid Muhammad
Maham Rafiq
Rabia Khan
Akif Saeed Ch

Abstract

Background: Polyphenol-rich dietary interventions may influence glycation-related and inflammatory biomarkers, but genetic modification of these responses remains uncertain. Objective: To assess biomarker responses to a polyphenol-rich Mediterranean diet and investigate modification by AGER rs2070600 and SOD2 rs4880. Methods: A 16-week randomized, parallel-group trial enrolled 84 adults aged 35–65 years with overweight or class I obesity in urban and industrial Punjab, Pakistan. Participants received dietary counseling and polyphenol-rich foods or a standard dietary control condition. Serum carboxymethyl-lysine (CML), high-sensitivity C-reactive protein (hs-CRP), and interleukin-6 (IL-6) were measured at baseline and week 16. Analyses used repeated-measures ANOVA and general linear models incorporating time × dietary group × genotype interactions. Results: Seventy-eight participants completed follow-up: 40 intervention and 38 control. CML decreased by 74.3 ng/mL (23.8%) versus 6.4 ng/mL (2.1%), respectively. Intervention–control differences in mean changes were −67.9 ng/mL for CML, −1.04 mg/L for hs-CRP, and −1.27 pg/mL for IL-6; reported time × group p-values were <0.001. Genetic effect modification remained unresolved because genotype-stratified summaries were inconsistent with overall results. Conclusion: The intervention was associated with greater short-term biomarker reductions among completers. Clinical benefit and genotype-guided dietary utility were not established

Article Details

Section

Articles

How to Cite

[1]
Iqra Walayat et al. 2026. Investigating the Interaction Between a Polyphenol-Rich Mediterranean Diet and Genetic Variants on Advanced Glycation End-Product (AGE) Level. Journal of Health, Wellness and Community Research. 4, 6 (Mar. 2026), 1–7. DOI:https://doi.org/10.61919/se4a8249.

References

1. Zaki HA, Bensliman S, Bashir K, Iftikhar H, Fayed MH, Salem W, Elmoheen A, Yigit Y. Accuracy of procalcitonin for diagnosing sepsis in adult patients admitted to the emergency department: a systematic review and meta-analysis. Systematic Reviews. 2024 Jan 22;13(1):37.

2. Downes KJ, Fitzgerald JC, Weiss SL. Utility of procalcitonin as a biomarker for sepsis in children. Journal of clinical microbiology. 2020 Jun 24;58(7):10-128.

3. Gregoriano C, Heilmann E, Molitor A, Schuetz P. Role of procalcitonin use in the management of sepsis. Journal of thoracic disease. 2020 Feb;12(Suppl 1):S5.

4. Moustafa R, Albouni T, Aziz G. The role of procalcitonin and presepsin in the septic febrile neutropenia in acute leukemia patients. PLoS One. 2021 Jul 29;16(7):e0253842.

5. Godi I, De Rosa S, Martino F, Bazzano S, Martin M, Boni E, Carta MR, Tamayo Diaz C, Mari G, Lorenzin A, de Cal M. Urinary [TIMP-2]×[IGFBP7] and serum procalcitonin to predict and assess the risk for short-term outcomes in septic and non-septic critically ill patients. Annals of Intensive Care. 2020 Apr 21;10(1):46.

6. Malik M, Nair AS, Illango J, Siddiqui N, Gor R, Fernando RW, Hamid P, Siddiqui NA, Fernando RW, Hamid PF. The advancement in detecting sepsis and its outcome: usefulness of procalcitonin in diagnosing sepsis and predicting fatal outcomes in patients admitted to intensive care unit. Cureus. 2021 Apr 12;13(4).

7. Liang P, Yu F. Value of CRP, PCT, and NLR in prediction of severity and prognosis of patients with bloodstream infections and sepsis. Frontiers in Surgery. 2022 Mar 7;9:857218.

8. Chen J, Tu X, Huang M, Xie Y, Lin Y, Hu J. Prognostic value of platelet combined with serum procalcitonin in patients with sepsis. Medicine. 2023 Aug 25;102(34):e34953.

9. Azad BJ, Yaseri M, Daneshzad E, Koohdani F. Interaction between Apo A-II-265T> C polymorphism and dietary total antioxidant capacity on some anthropometric indices and serum lipid profile in patients with type 2 diabetes mellitus. Journal of nutritional science. 2021 Jan;10:e9.

10. Bucciantini M, Leri M, Nardiello P, Casamenti F, Stefani M. Olive polyphenols: Antioxidant and anti-inflammatory properties. Antioxidants. 2021 Jun 29;10(7):1044.

11. Bhori M, Rastogi V, Tungare K, Marar T. A review on interplay between obesity, lipoprotein profile and nutrigenetics with selected candidate marker genes of type 2 diabetes mellitus. Molecular biology reports. 2022 Jan;49(1):687-703.

12. Baykara O. Effects of Natural Products on the Genetics of Gestational Diabetes Mellitus. Natural Products and their Bioactives in Antidiabetic Drug Discovery. 2023 Jul 18.

13. Pérusse L, Martínez JA, de la Garza AL, Pérez ES, Lomelí ML, Barrera ME. 15th Congress of the International Society of Nutrigenetics & Nutrigenomics (ISNN).

14. Fabozzi G, Verdone G, Allori M, Cimadomo D, Tatone C, Stuppia L, Franzago M, Ubaldi N, Vaiarelli A, Ubaldi FM, Rienzi L. Personalized nutrition in the management of female infertility: new insights on chronic low-grade inflammation. Nutrients. 2022 May 3;14(9):1918.

15. Bucciantini M, Leri M, Nardiello P, Casamenti F, Stefani M. Olive Polyphenols: Antioxidant and Anti-Inflammatory Properties. Antioxidants 2021, 10, 1044. Diet. Polyphen. Neuroprotection. 2021;71.

16. Aboufarrag H, Hollands WJ, Percival J, Philo M, Savva GM, Kroon PA. No Effect of Isolated Anthocyanins From Bilberry Fruit and Black Rice on LDL Cholesterol or Other Biomarkers of Cardiovascular Disease in Adults With Elevated Cholesterol: A Randomized, Placebo‐Controlled, Cross‐Over Trial. Molecular nutrition & food research. 2022 Nov;66(21):2101157.